Iridex Affirms FY2026 Sales Guidance of $51.000M-$53.000M vs $53.227M Est

Benzinga Newsdesk www.benzinga.com Negative 66.4%

Neg 66.4% Neu 0% Pos 0%

Iridex (NASDAQ:IRIX) affirms FY2026 sales outlook from $51.000 million-$53.000 million to $51.000 million-$53.000 million vs $53.227 million estimate.